Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study.

Croat Med J · 2019 · PMC6509622 · PMID 31044590

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

borderline significantP = 0.063so close (0.05 < p ≤ 0.1)

They also had lower severity of depressive symptoms (borderline significant, P = 0.063), needed more time to complete the first part of the Stroop test ( P = 0.03), and had worse score on the first part of the VFT ( P < 0.001).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.